Insufficient stocking of poisoning antidotes in hospital pharmacies

JAMA

Volumn 276, Issue 18, 1996, Pages 1508-1510

  Dart, Richard C ^a,c   Stark, Yvonne ^a   Fulton, Bret ^a   Koziol McLain, Jane ^b   Lowenstein, Steven R ^b  

^a Denver Department of Health and Hospitals   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDOTE; DEFEROXAMINE MESYLATE; DIGOXIN ANTIBODY; NALOXONE; PRALIDOXIME CHLORIDE; PYRIDOXINE; VENOM ANTISERUM;

ARTICLE; EMERGENCY TREATMENT; HEALTH CARE AVAILABILITY; HOSPITAL MANAGEMENT; HOSPITAL PHARMACY; INTOXICATION; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

EID: 0029975778     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.18.1508     Document Type: Article

References (20)

1. Litovitz TL, Clark LR, Soloway RA. 1993 report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1994;12:546-584.
2. Joint Commission on Accreditation of Healthcare Organizations. Accreditation Manual for Hospitals. Oakbrook Terrace, Ill: Joint Commission on Accreditation of Healthcare Organizations; 1992;1:111.
3. Coe C. Update to Joint Hospital Accreditation Standards. Bethesda, Md: American Society of Hospital Pharmacists; 1994:26.
4. Criteria for Certification as a Regional Poison Center. Washington, DC: American Association of Poison Control Centers; 1991.
5. Howland MA, Weisman R, Sauter D, Goldfrank L. Nonavailability of poison antidotes. N Engl J Med. 1986;314:927-928.
6. American Hospital Association Guide to the Health Care Field. Chicago, Ill: American Hospital Association; 1993:A78-A84, A266-A270, A278-A280.
7. Digibind package insert. Physicians' Desk Reference. 50th ed. Montvale, NJ: medical Economics Co; 1996:1092.
8. Howland MA. Pyridoxine. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994:636-638.
9. Howland MA. Ethanol. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994:841-843.
10. Howland MA, Aaron C. Pralidoxime. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994:1117-1119.
11. Roberts JR, Otten EJ. Antivenin. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994:1313-1316.
12. Howland MA, Deferoxamine. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994:532-534.
13. Rumack BH, Hess AJ, Gelman CR, eds. POIS-INDEX System. Englewood, Colo: Micromedex Inc; 1996;87.
14. Weisman R. Naloxone. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994:784-786.
15. Drug Topics Redbook. Montvale, NJ: Medical Economics Co; 1995.
16. Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning. Clin Toxicol. 1973;6:153-162.
17. Antman EM, Wenger TL, Butler VP, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Circulation. 1990;81:1744-1752.
18. Kanatani MS, Kearney TE, Levin RH, Heard SE. Treatment of toxicologic emergencies: an evaluation of Bay Area hospital pharmacies and its impact on emergency planning. Vet Hum Toxicol. 1992;34:319. Abstract.
19. Dart RC, Duncan C, McNally JT. Effect of inadequate antivenin stores on the medical treatment of crotalid envenomation. Vet Hum Toxicol. 1991;33:267-269.
20. Chyka PA, Conner HG. Availability of antidotes in rural and urban hospitals in Tennessee. Am J Hosp Pharm. 1994;51:1346-1348.